Author

E. Funck-Brentano

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:rat· 1

Frequent Co-Authors

D. Vizlin Hodzic· 1 shared J. A. Nilsson· 1 shared L. M. Nilsson· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

D. Vizlin Hodzic

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma

E. Funck-Brentano, D. Vizlin Hodzic, J. A. Nilsson, L. M. Nilsson

The paper identifies that BET bromodomain inhibitors like HMBA synergize with MEK inhibitors to enhance apoptosis in glioma cells, both in vitro and in vivo.

bioRxiv · Jan 1, 2020Cancer Biology